This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Riedell, Peter
Item Type | Name |
Concept
|
Antibiotics, Antineoplastic
|
Concept
|
Cyclic AMP
|
Concept
|
Antineoplastic Agents
|
Concept
|
Antiviral Agents
|
Concept
|
Antibodies, Monoclonal
|
Concept
|
Biological Products
|
Concept
|
C-Reactive Protein
|
Concept
|
Cyclophosphamide
|
Concept
|
Cytarabine
|
Concept
|
Fatty Acids, Volatile
|
Concept
|
Hydrazines
|
Concept
|
Oleic Acids
|
Concept
|
Melphalan
|
Concept
|
Prednisone
|
Concept
|
Interleukin-6
|
Concept
|
Thiotepa
|
Concept
|
Troponin
|
Concept
|
Drug Resistance, Neoplasm
|
Concept
|
Cyclic AMP Response Element-Binding Protein
|
Concept
|
Proto-Oncogene Proteins c-myc
|
Concept
|
Fluorodeoxyglucose F18
|
Concept
|
Antigens, CD19
|
Concept
|
Cladribine
|
Concept
|
B7-H1 Antigen
|
Concept
|
Proto-Oncogene Proteins c-bcl-2
|
Concept
|
Anthracyclines
|
Concept
|
Sulfonamides
|
Concept
|
Triazoles
|
Concept
|
Antibodies, Monoclonal, Humanized
|
Concept
|
Steroids
|
Concept
|
Vincristine
|
Concept
|
Antibodies, Monoclonal, Murine-Derived
|
Concept
|
Doxorubicin
|
Concept
|
Receptors, Antigen, T-Cell
|
Concept
|
Cyclic AMP-Dependent Protein Kinases
|
Concept
|
Bridged Bicyclo Compounds, Heterocyclic
|
Concept
|
5-Methylcytosine
|
Academic Article
|
A drug safety evaluation of rituximab and risk of hepatitis B.
|
Academic Article
|
Safety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas.
|
Academic Article
|
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
|
Academic Article
|
Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results.
|